[
    {
        "id": "4709492",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2024-08-01T20:37:41-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated 2024 Q2 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4709492-vertex-pharmaceuticals-incorporated-2024-q2-results-earnings-call-presentation"
        }
    },
    {
        "id": "4709491",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-08-01T20:37:09-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals, Inc. (VRTX) Q2 2024 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4709491-vertex-pharmaceuticals-inc-vrtx-q2-2024-earnings-call-transcript"
        }
    },
    {
        "id": "4698709",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-06-11T16:22:10-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4698709-vertex-pharmaceuticals-incorporated-vrtx-goldman-sachs-45th-annual-global-healthcare"
        }
    },
    {
        "id": "4698090",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-06-07T12:56:03-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) The 44th Annual William Blair Growth Stock Conference",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4698090-vertex-pharmaceuticals-incorporated-vrtx-44th-annual-william-blair-growth-stock-conference"
        }
    },
    {
        "id": "4689948",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-05-06T21:31:02-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals, Inc. (VRTX) Q1 2024 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4689948-vertex-pharmaceuticals-inc-vrtx-q1-2024-earnings-call-transcript"
        }
    },
    {
        "id": "4677486",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-03-11T23:14:04-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) Leerink Partners Global Biopharma Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4677486-vertex-pharmaceuticals-incorporated-vrtx-leerink-partners-global-biopharma-conference"
        }
    },
    {
        "id": "4676058",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-03-05T14:52:03-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) TD Cowen 44th Annual Health Care Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4676058-vertex-pharmaceuticals-incorporated-vrtx-td-cowen-44th-annual-health-care-conference"
        }
    },
    {
        "id": "4667658",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-02-05T20:49:07-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) Q4 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4667658-vertex-pharmaceuticals-incorporated-vrtx-q4-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4667643",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2024-02-05T18:58:58-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated 2023 Q4 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4667643-vertex-pharmaceuticals-incorporated-2023-q4-results-earnings-call-presentation"
        }
    },
    {
        "id": "4661737",
        "type": "transcript",
        "attributes": {
            "publishOn": "2024-01-08T13:39:09-05:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) J.P. Morgan 42nd Annual Healthcare Conference",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4661737-vertex-pharmaceuticals-incorporated-vrtx-j-p-morgan-42nd-annual-healthcare-conference"
        }
    },
    {
        "id": "4651768",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-11-14T16:44:08-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) Jefferies Global Healthcare Conference Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4651768-vertex-pharmaceuticals-incorporated-vrtx-jefferies-global-healthcare-conference-call"
        }
    },
    {
        "id": "4650825",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-11-11T13:50:06-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) Presents at UBS Biopharma Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4650825-vertex-pharmaceuticals-incorporated-vrtx-presents-ubs-biopharma-conference-transcript"
        }
    },
    {
        "id": "4648186",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-11-06T19:17:07-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) Q3 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4648186-vertex-pharmaceuticals-incorporated-vrtx-q3-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4648149",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2023-11-06T16:41:47-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated 2023 Q3 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4648149-vertex-pharmaceuticals-incorporated-2023-q3-results-earnings-call-presentation"
        }
    },
    {
        "id": "4635026",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-09-13T16:50:19-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) Morgan Stanley 21st Annual Global Healthcare Conference 2023 (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4635026-vertex-pharmaceuticals-incorporated-vrtx-morgan-stanley-21st-annual-global-healthcare"
        }
    },
    {
        "id": "4628166",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2023-08-14T10:24:57-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated 2023 Q2 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4628166-vertex-pharmaceuticals-incorporated-2023-q2-results-earnings-call-presentation"
        }
    },
    {
        "id": "4622513",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-08-01T22:53:02-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) Q2 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4622513-vertex-pharmaceuticals-incorporated-vrtx-q2-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4611331",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-06-13T22:30:09-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) Goldman Sachs 44th Annual Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4611331-vertex-pharmaceuticals-incorporated-vrtx-goldman-sachs-44th-annual-global-healthcare"
        }
    },
    {
        "id": "4604148",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-05-13T19:05:24-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) Presents at BofA Securities 2023 Health Care Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4604148-vertex-pharmaceuticals-incorporated-vrtx-presents-bofa-securities-2023-health-care-conference"
        }
    },
    {
        "id": "4598675",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-05-01T21:37:06-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) Q1 2023 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4598675-vertex-pharmaceuticals-incorporated-vrtx-q1-2023-earnings-call-transcript"
        }
    },
    {
        "id": "4598628",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2023-05-01T16:38:51-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated 2023 Q1 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4598628-vertex-pharmaceuticals-incorporated-2023-q1-results-earnings-call-presentation"
        }
    },
    {
        "id": "4585431",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-03-07T19:51:05-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) 43rd Annual Cowen Healthcare Conference Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4585431-vertex-pharmaceuticals-incorporated-vrtx-43rd-annual-cowen-healthcare-conference-transcript"
        }
    },
    {
        "id": "4576163",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-02-07T21:10:25-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) Q4 2022 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4576163-vertex-pharmaceuticals-incorporated-vrtx-q4-2022-earnings-call-transcript"
        }
    },
    {
        "id": "4576124",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2023-02-07T18:09:47-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated 2022 Q4 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4576124-vertex-pharmaceuticals-incorporated-2022-q4-results-earnings-call-presentation"
        }
    },
    {
        "id": "4568768",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2023-01-09T13:06:02-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "41st Annual J.P. Morgan Healthcare Conference",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4568768-41st-annual-j-p-morgan-healthcare-conference"
        }
    },
    {
        "id": "4568767",
        "type": "transcript",
        "attributes": {
            "publishOn": "2023-01-09T13:04:05-05:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) 41st Annual J.P. Morgan Healthcare Conference - (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4568767-vertex-pharmaceuticals-incorporated-vrtx-41st-annual-j-p-morgan-healthcare-conference"
        }
    },
    {
        "id": "4561803",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-12-01T14:03:02-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated present at 5th Annual Evercore ISI HealthCONx Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4561803-vertex-pharmaceuticals-incorporated-present-5th-annual-evercore-isi-healthconx-conference"
        }
    },
    {
        "id": "4558386",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-11-16T09:26:05-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) Jefferies London Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4558386-vertex-pharmaceuticals-incorporated-vrtx-jefferies-london-healthcare-conference-transcript"
        }
    },
    {
        "id": "4550194",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-10-27T21:29:06-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) Q3 2022 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4550194-vertex-pharmaceuticals-incorporated-vrtx-q3-2022-earnings-call-transcript"
        }
    },
    {
        "id": "4550164",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2022-10-27T20:07:34-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated 2022 Q3 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4550164-vertex-pharmaceuticals-incorporated-2022-q3-results-earnings-call-presentation"
        }
    },
    {
        "id": "4529974",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-08-04T20:35:23-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals, Inc. (VRTX) CEO Reshma Kewalramani on Q2 2022 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4529974-vertex-pharmaceuticals-inc-vrtx-ceo-reshma-kewalramani-on-q2-2022-results-earnings-call"
        }
    },
    {
        "id": "4529973",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2022-08-04T20:34:15-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated 2022 Q2 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4529973-vertex-pharmaceuticals-incorporated-2022-q2-results-earnings-call-presentation"
        }
    },
    {
        "id": "4518660",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-06-15T18:51:05-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) CEO Reshma Kewalramani on Goldman Sachs 43rd Annual Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4518660-vertex-pharmaceuticals-incorporated-vrtx-ceo-reshma-kewalramani-on-goldman-sachs-43rd-annual"
        }
    },
    {
        "id": "4508172",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2022-05-06T16:03:27-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated 2022 Q1 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4508172-vertex-pharmaceuticals-incorporated-2022-q1-results-earnings-call-presentation"
        }
    },
    {
        "id": "4507598",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-05-05T21:05:03-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) CEO Dr. Reshma Kewalramani on Q1 2022 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4507598-vertex-pharmaceuticals-incorporated-vrtx-ceo-dr-reshma-kewalramani-on-q1-2022-results"
        }
    },
    {
        "id": "4493884",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-03-08T18:14:03-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals, Inc. (VRTX) Presents at Cowen Health Care Broker Conference Call - (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4493884-vertex-pharmaceuticals-inc-vrtx-presents-cowen-health-care-broker-conference-call-transcript"
        }
    },
    {
        "id": "4481921",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-01-26T21:31:01-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals, Inc. (VRTX) CEO Reshma Kewalramani on Q4 2021 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4481921-vertex-pharmaceuticals-inc-vrtx-ceo-reshma-kewalramani-on-q4-2021-results-earnings-call"
        }
    },
    {
        "id": "4479337",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2022-01-12T15:45:50-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals (VRTX) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4479337-vertex-pharmaceuticals-vrtx-presents-40th-annual-j-p-morgan-virtual-healthcare-conference"
        }
    },
    {
        "id": "4478807",
        "type": "transcript",
        "attributes": {
            "publishOn": "2022-01-10T12:14:07-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated's (VRTX) CEO Reshma Kewalramani Presents at 40th Annual JPMorgan Healthcare Conference - Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4478807-vertex-pharmaceuticals-incorporateds-vrtx-ceo-reshma-kewalramani-presents-40th-annual"
        }
    },
    {
        "id": "4465043",
        "type": "earningsSlide",
        "attributes": {
            "publishOn": "2021-11-03T15:47:46-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated 2021 Q3 - Results - Earnings Call Presentation",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "568658",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/4465043-vertex-pharmaceuticals-incorporated-2021-q3-results-earnings-call-presentation"
        }
    },
    {
        "id": "1872701",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-12-02T20:02:02-05:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals' Management Presents at 2013 Deutsche Bank BioFEST Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1872701-vertex-pharmaceuticals-management-presents-at-2013-deutsche-bank-biofest-conference-transcript"
        }
    },
    {
        "id": "1782822",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-10-29T13:20:16-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated Management Discusses Q3 2013 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1782822-vertex-pharmaceuticals-incorporated-management-discusses-q3-2013-results-earnings-call-transcript"
        }
    },
    {
        "id": "1684522",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-09-10T12:41:01-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals' Management Presents at Morgan Stanley Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1684522-vertex-pharmaceuticals-management-presents-at-morgan-stanley-global-healthcare-conference-transcript"
        }
    },
    {
        "id": "1582202",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-07-29T22:00:07-04:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated Management Discusses Q2 2013 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1582202-vertex-pharmaceuticals-incorporated-management-discusses-q2-2013-results-earnings-call-transcript"
        }
    },
    {
        "id": "1580882",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-07-29T17:08:10-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated (VRTX) Management Discusses Q2 2013 Results (Webcast)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1580882-vertex-pharmaceuticals-incorporated-vrtx-management-discusses-q2-2013-results-webcast"
        }
    },
    {
        "id": "1495302",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-06-11T16:50:04-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-11-2013 10:00 AM",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1495302-vertex-pharmaceuticals-incorporated-presents-at-goldman-sachs-34th-annual-global-healthcare-conference-junminus-11minus-2013-10-00-am"
        }
    },
    {
        "id": "1387481",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-04-30T21:50:09-04:00",
            "isLockedPro": false,
            "commentCount": 3,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated Management Discusses Q1 2013 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1387481-vertex-pharmaceuticals-incorporated-management-discusses-q1-2013-results-earnings-call-transcript"
        }
    },
    {
        "id": "1353641",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-04-19T03:40:04-04:00",
            "isLockedPro": false,
            "commentCount": 5,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals' CEO Hosts Phase II Results for VX-661 Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1353641-vertex-pharmaceuticals-ceo-hosts-phase-ii-results-for-vxminus-661-conference-transcript"
        }
    },
    {
        "id": "1267771",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-03-12T16:10:06-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals' Management Presents at Barclays Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1267771-vertex-pharmaceuticals-management-presents-at-barclays-global-healthcare-conference-transcript"
        }
    },
    {
        "id": "1245651",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-02-27T00:15:00-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated - Special Call",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1245651-vertex-pharmaceuticals-incorporated-special-call"
        }
    },
    {
        "id": "1142341",
        "type": "transcript",
        "attributes": {
            "publishOn": "2013-01-29T21:36:01-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated CEO discusses Q4 2012 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/1142341-vertex-pharmaceuticals-incorporated-ceo-discusses-q4-2012-results-earnings-call-transcript"
        }
    },
    {
        "id": "971831",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-11-01T23:20:06-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated Management Discusses Q3 2012 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/971831-vertex-pharmaceuticals-incorporated-management-discusses-q3-2012-results-earnings-call-transcript"
        }
    },
    {
        "id": "763801",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-07-31T01:16:03-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/763801-vertex-pharmaceuticals-ceo-discusses-q2-2012-results-earnings-call-transcript"
        }
    },
    {
        "id": "581221",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-05-11T10:57:04-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex's Management Present at Deutsche Bank Securities, Inc. 37th Annual Health Care Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/581221-vertexs-management-present-at-deutsche-bank-securities-inc-37th-annual-health-care-conference-transcript"
        }
    },
    {
        "id": "534411",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-04-26T21:50:07-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated's CEO Discusses Q1 2012 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/534411-vertex-pharmaceuticals-incorporateds-ceo-discusses-q1-2012-results-earnings-call-transcript"
        }
    },
    {
        "id": "338401",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-02-02T23:47:07-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/338401-vertex-pharmaceuticals-ceo-discusses-q4-2011-results-earnings-call-transcript"
        }
    },
    {
        "id": "318432",
        "type": "transcript",
        "attributes": {
            "publishOn": "2012-01-09T19:37:14-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals' CEO Presents at JPMorgan Global Healthcare Conference (Transcript)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/318432-vertex-pharmaceuticals-ceo-presents-at-jpmorgan-global-healthcare-conference-transcript"
        }
    },
    {
        "id": "306693",
        "type": "transcript",
        "attributes": {
            "publishOn": "2011-11-09T15:31:19-05:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals at Credit Suisse 2011 Healthcare Conference Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/306693-vertex-pharmaceuticals-at-credit-suisse-2011-healthcare-conference-call-transcript"
        }
    },
    {
        "id": "303090",
        "type": "transcript",
        "attributes": {
            "publishOn": "2011-10-28T03:50:10-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated's CEO Discusses Q3 2011 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/303090-vertex-pharmaceuticals-incorporateds-ceo-discusses-q3-2011-results-earnings-call-transcript"
        }
    },
    {
        "id": "282988",
        "type": "transcript",
        "attributes": {
            "publishOn": "2011-07-29T03:10:09-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated's CEO Discusses Q2 2011 Results - Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/282988-vertex-pharmaceuticals-incorporateds-ceo-discusses-q2-2011-results-earnings-call-transcript"
        }
    },
    {
        "id": "186865",
        "type": "transcript",
        "attributes": {
            "publishOn": "2010-02-05T02:05:17-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Inc. Q4 2009 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/186865-vertex-pharmaceuticals-inc-q4-2009-earnings-call-transcript"
        }
    },
    {
        "id": "168960",
        "type": "transcript",
        "attributes": {
            "publishOn": "2009-10-26T22:23:15-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Q3 2009 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/168960-vertex-pharmaceuticals-q3-2009-earnings-call-transcript"
        }
    },
    {
        "id": "119488",
        "type": "transcript",
        "attributes": {
            "publishOn": "2009-02-09T20:06:09-05:00",
            "isLockedPro": false,
            "commentCount": 1,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated, Q4 2008 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/119488-vertex-pharmaceuticals-incorporated-q4-2008-earnings-call-transcript"
        }
    },
    {
        "id": "102228",
        "type": "transcript",
        "attributes": {
            "publishOn": "2008-10-27T23:43:13-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated Q3 2008 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/102228-vertex-pharmaceuticals-incorporated-q3-2008-earnings-call-transcript"
        }
    },
    {
        "id": "88452",
        "type": "transcript",
        "attributes": {
            "publishOn": "2008-07-31T23:00:35-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated. Q2 2008 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/88452-vertex-pharmaceuticals-incorporated-q2-2008-earnings-call-transcript"
        }
    },
    {
        "id": "73206",
        "type": "transcript",
        "attributes": {
            "publishOn": "2008-04-21T23:02:07-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Q1 2008 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/73206-vertex-pharmaceuticals-q1-2008-earnings-call-transcript"
        }
    },
    {
        "id": "64143",
        "type": "transcript",
        "attributes": {
            "publishOn": "2008-02-11T22:34:08-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Inc. Q4 2007 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/64143-vertex-pharmaceuticals-inc-q4-2007-earnings-call-transcript"
        }
    },
    {
        "id": "51959",
        "type": "transcript",
        "attributes": {
            "publishOn": "2007-10-30T06:46:39-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Inc. Q3 2007 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/51959-vertex-pharmaceuticals-inc-q3-2007-earnings-call-transcript"
        }
    },
    {
        "id": "42167",
        "type": "transcript",
        "attributes": {
            "publishOn": "2007-07-24T21:39:06-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Q2 2007 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/42167-vertex-pharmaceuticals-q2-2007-earnings-call-transcript"
        }
    },
    {
        "id": "34029",
        "type": "transcript",
        "attributes": {
            "publishOn": "2007-04-30T21:55:31-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Q1 2007 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/34029-vertex-pharmaceuticals-q1-2007-earnings-call-transcript"
        }
    },
    {
        "id": "25843",
        "type": "transcript",
        "attributes": {
            "publishOn": "2007-02-01T21:25:09-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Q4 2006 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/25843-vertex-pharmaceuticals-q4-2006-earnings-call-transcript"
        }
    },
    {
        "id": "19369",
        "type": "transcript",
        "attributes": {
            "publishOn": "2006-10-26T20:12:35-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Q3 2006 Earnings Call Transcript",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/19369-vertex-pharmaceuticals-q3-2006-earnings-call-transcript"
        }
    },
    {
        "id": "14401",
        "type": "transcript",
        "attributes": {
            "publishOn": "2006-07-27T07:37:25-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Q2 2006 Earnings Conference Call Transcript (VRTX)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/14401-vertex-pharmaceuticals-q2-2006-earnings-conference-call-transcript-vrtx"
        }
    },
    {
        "id": "9519",
        "type": "transcript",
        "attributes": {
            "publishOn": "2006-04-25T18:40:11-04:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated Q1 2006 Earnings Results Conference Call Transcript (VRTX)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/9519-vertex-pharmaceuticals-incorporated-q1-2006-earnings-results-conference-call-transcript-vrtx"
        }
    },
    {
        "id": "6677",
        "type": "transcript",
        "attributes": {
            "publishOn": "2006-02-09T14:09:37-05:00",
            "isLockedPro": false,
            "commentCount": 0,
            "gettyImageUrl": null,
            "videoPreviewUrl": null,
            "videoDuration": null,
            "themes": {},
            "title": "Vertex Pharmaceuticals Incorporated Q4 2005 Earnings Conference Call Transcript (VRTX)",
            "structuredInsights": null,
            "isPaywalled": false
        },
        "relationships": {
            "author": {
                "data": {
                    "id": "44211",
                    "type": "author"
                }
            },
            "sentiments": {
                "data": []
            },
            "primaryTickers": {
                "data": [
                    {
                        "id": "1102",
                        "type": "tag"
                    }
                ]
            },
            "secondaryTickers": {
                "data": []
            },
            "otherTags": {
                "data": [
                    {
                        "id": "49",
                        "type": "tag"
                    }
                ]
            }
        },
        "links": {
            "self": "/article/6677-vertex-pharmaceuticals-incorporated-q4-2005-earnings-conference-call-transcript-vrtx"
        }
    }
]